Nido Biosciences
Boston, US · Founded 2018 · Delaware corporation · 5 known investors
Find your way into Nido Biosciences
Sign up to see every warm intro you have to Nido Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nido Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JB

EE
Elliot EhrichNamed on SEC filing
Board
AS
Investors · 5
5AM VenturesreportedSan Francisco · $100K – $4M
How we know: funding news · biospace.com · Not right? Tell us
AbingworthreportedLondon · $15M – $30M
How we know: funding news · biospace.com · Not right? Tell us
Bessemer Venture PartnersreportedSan Francisco · $50K – $100M
How we know: funding news · biospace.com · Not right? Tell us
Bioluminescence VenturesreportedSan Francisco
How we know: funding news · biospace.com · Not right? Tell us
Also in the syndicate · 1
Eli Lilly
Funding
SEC filings, press & company announcements$131.4M disclosed across 3 rounds · 2019–2023
- $109MraisedMay 2023 · 2 sources
Bioluminescence Ventures (lead), 5AM, Abingworth, Bessemer Venture Partners, Eli Lilly, Osage University Partners
Source ↗
▶$18.4MraisedSep 2020 · 6 investors · OtherRule 506(b)
▶$18.4MraisedSep 2020 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Andrew HedinDirector
- Jamil BegExecutive Officer, Director
- Jacqueline GrantDirector
- Offering amount
- $46M
- Amount sold
- $18.4M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$4MraisedSep 2019 · 1 investors · OtherRule 506(b)
▶$4MraisedSep 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jamil BegExecutive Officer, Director
- Elliot EhrichDirector
- Andrew SchwabDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nido Biosciences's investors?
- Nido Biosciences's investors include 5AM Ventures, Abingworth, Bessemer Venture Partners, Bioluminescence Ventures.
- How much funding has Nido Biosciences raised?
- Nido Biosciences has disclosed $131.4M raised across 3 rounds.
- Where is Nido Biosciences headquartered?
- Nido Biosciences is headquartered in Boston, US.


